Clinical Trial Update: Assessment of Insulin Resistance, NAFLD, Predictors of CV Morbidity, and Subcutaneous Adipose and Visceral Adipose Gene Expression in Patients Undergoing Gastric Bypass Surgery

View source ↗

Summary

This clinical trial update reports on assessing insulin resistance, non-alcoholic fatty liver disease, predictors of cardiovascular morbidity, and adipose tissu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Morbid Obesity
• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Morbid Obesity, Insulin Resistance | Status: COMPLETED